LOGIN  |  REGISTER
Terns Pharmaceuticals
C4 Therapeutics

MSP Recovery D/B/A LifeWallet, Begins Trading Today Under New NASDAQ Ticker Symbol LIFW

January 03, 2023 | Last Trade: US$1.79 0.12 -6.28

CORAL GABLES, Fla., Jan. 03, 2023 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. D/B/A LifeWallet (“LifeWallet”, or “the Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced the Company will commence trading of its common stock today, January 3, 2023 at 9:30 AM ET, under the new ticker symbol “LIFW”.

MSP Recovery, Inc. previously announced on Dec 22, 2022 that it will begin doing business as “LifeWallet” in 2023.

The “LIFW” ticker symbol will replace the Company’s current ticker symbol for its common stock, “MSPR”. Additionally, the Company’s publicly traded warrants to purchase common stock will begin trading under the ticker symbols “LIFWW” and “LIFWZ”, thus replacing the Company’s ticker symbols for its publicly traded warrants, “MSPRW” and “MSPRZ”, respectively.

The Company will not change its core strategy, and the core business remains the same – secondary payer reimbursement recoveries.

“Transitioning to a new stock ticker is the most recent step we have taken toward our rebranding initiative with the intention of further strengthening our core business,” said MSP Recovery/LifeWallet Founder and CEO, John H. Ruiz. “This is an exciting time for the business as we continue to integrate and align ourselves with the nationally-recognized LifeWallet brand.”

No action is required by the Company’s current shareholders as a result of the change. The ticker symbol change will have no effect on business goals, strategy, or fees and expenses.

For more information, the Company recommends that stockholders, investors, and any other interested parties read the Company’s public filings and press releases available at investor.lifewallet.com.

About LifeWallet

Founded in 2014 as MSP Recovery, LifeWallet has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries from responsible parties. The LifeWallet ecosystem provides innovative solutions for multiple industries including sports, schools, legal, and healthcare, while innovating technologies to help save lives. For more information, visit: lifewallet.com

Forward Looking Statement

This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by LIFW in this press release, its reports filed with the Securities and Exchange Commission (the "SEC") and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for LIFW to predict or identify all such events or how they may affect it. LIFW has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, LIFW’s ability to capitalize on its assignment agreements and recover monies that were paid by the assignors; litigation results; the validity of the assignments of claims to LIFW; the inability to successfully expand the scope of LIFW’s claims or obtain new data and claims from LIFW’s existing assignor base or otherwise; LIFW’s failure to innovate and develop new solutions, or the failure of those solutions to be adopted by LIFW’s existing and potential assignors; negative publicity concerning healthcare data analytics and payment accuracy. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.

For Media:
ICR, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.

Marc Griffin
This email address is being protected from spambots. You need JavaScript enabled to view it.


Viking Therapeutics

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB